Barlow Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.31M Hold
5,739
– – 0.24% 41
2026
Q2
$2.11M Hold
5,739
– – 0.23% 44
2026
Q1
$2.04M Hold
5,739
– – 0.23% 41
2025
Q4
$1.87M Sell
5,739
-1,104
-16% -$350K 0.2% 42
2025
Q3
$2.03M Hold
6,843
– – 0.23% 41
2025
Q2
$2.03M Sell
6,843
-152
-2% -$43.1K 0.24% 44
2025
Q1
$1.96M Sell
6,995
-82
-1% -$24.2K 0.26% 44
2024
Q4
$1.9M Sell
7,077
-781
-10% -$232K 0.24% 46
2024
Q3
$2.49M Hold
7,858
– – 0.33% 46
2024
Q2
$2.64M Hold
7,858
– – 0.37% 44
2024
Q1
$2.1M Sell
7,858
-25
-0.3% -$7.32K 0.29% 54
2023
Q4
$2.27M Buy
+7,883
New +$2.15M 0.32% 49

Other funds holding AMGN

Barlow Wealth Partners's AMGN Position: Q3 2026 in Review

Barlow Wealth Partners held its Amgen (AMGN) position steady in Q3 2026 at 5,739 shares worth $2.31M. The position accounts for 0.24% of the portfolio, ranked #41.

Barlow Wealth Partners first reported a position in AMGN in Q4 2023 and has held it in 12 quarters since. The position peaked at $2.64M in Q2 2024. 2,024 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Barlow Wealth Partners held 5,739 shares of Amgen worth $2.31M as of Q3 2026.
  • Barlow Wealth Partners left its Amgen share count unchanged in Q3 2026.
  • Amgen made up 0.24% of Barlow Wealth Partners's portfolio in Q3 2026, its #41 holding.
  • Barlow Wealth Partners first reported a position in Amgen in Q4 2023 and has held it in 12 quarters since.
  • Barlow Wealth Partners's Amgen position peaked at $2.64M in Q2 2024.
  • 2,024 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Barlow Wealth Partners's 13F filing for Q3 2026, filed 15 Oct 2026.